Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Triple Negative Breast Cancer
Interventions: PROCEDURE: Needle core biopsies|PROCEDURE: Needle core biopsies of metastatic lesion
Sponsor: Jewish General Hospital
Collaborators: Exactis Innovation|Genome Quebec